Clinical Trial Update: Diindolylmethane in Treating Patients Undergoing Surgery for Stage I or Stage II Prostate Cancer [Phase 1]

View source ↗

Summary

This update reports the completion of a Phase 1 clinical trial evaluating diindolylmethane in patients undergoing surgery for early-stage prostate cancer.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Prostate Cancer

Drugs mentioned

• Diindolylmethane (diindolylmethane)

Snippet

Sponsor: National Cancer Institute (NCI) | Conditions: Adenocarcinoma of the Prostate, Prostate Cancer | Phase 1 | Status: COMPLETED